default author photo

Fara Brasó-Maristany

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

18

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

HER2DX Genomic Assay in HER2-Positive Early Breast Cancer Treated with Trastuzumab and Pertuzumab: A Correlative Analysis from a Real-World Cohort

Number of pages: 35 Posted: 11 Feb 2026
beatriz Alonso de castro, Sandra Cobo, María Alonso Pena, Julia Pérez Malillos, Cristina Reboredo Rendo, Eva Pérez López, Oleguer Castillo, Valeria Sirenko, Angela Aguirre, Paula Blasco, Lourdes Calvo Martínez, Patricia Galván, Esther Sanfeliu, Paula Saavedra Nieves, Ángel Concha López, Aleix Prat, Fara Brasó-Maristany and Silvia Antolín Novoa
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Instituto de Investigación Biomédica de A Coruña - Complexo Hospitalario Universitario A Coruña, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Clinic of Barcelona - Department of Medical Oncology, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 18 (1,481,165)

Abstract:

Loading...

HER2, Breast Cancer, HER2DX, trastuzumab, pertuzumab, Pathological complete response, neoadjuvant